These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

96 related articles for article (PubMed ID: 3103875)

  • 1. [Demonstration of an oxidative biotransformation of 9-methoxyellipticine. Comparison with the case of 9-hydroxyellipticine].
    Braham Y; Meunier G; Meunier B
    C R Acad Sci III; 1987; 304(11):301-6. PubMed ID: 3103875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Metabolism and pharmacokinetics of methoxy-9-ellipticine and its principal metabolite, hydroxy-9-ellipticine].
    Lecointe P; Puget A
    C R Seances Acad Sci III; 1983; 296(6):279-82. PubMed ID: 6405990
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metabolism of the anti-tumour drugs N2-methyl-9-hydroxyellipticinium acetate (NSC 264137) and N2-methyl-9-hydroxyolivacinium acetate in the rat: preliminary identification of biliary 9-(O)-glucuronide and 10-(S)-glutathione conjugates.
    Maftouh M; Meunier G; Dugue B; Monsarrat B; Meunier B; Paoletti C
    Xenobiotica; 1983 May; 13(5):303-10. PubMed ID: 6636827
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of the glucuronide and glutathione conjugates of the antitumor drug N2-methyl-9-hydroxyellipticinium acetate (Celiptium). Comparative disposition of this drug with its olivacinium isomer in rat bile.
    Maftouh M; Monsarrat B; Rao RC; Meunier B; Paoletti C
    Drug Metab Dispos; 1984; 12(1):111-9. PubMed ID: 6141901
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Microbial transformations of natural antitumor agents. VIII. Formation of 8- and 9-hydroxyellipticines.
    Chien MM; Rosazza JP
    Drug Metab Dispos; 1979; 7(4):211-4. PubMed ID: 39722
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Oxidation pattern of the anticancer drug ellipticine by hepatic microsomes - similarity between human and rat systems.
    Stiborová M; Borek-Dohalská L; Aimová D; Kotrbová V; Kukacková K; Janouchová K; Rupertová M; Ryslavá H; Hudecek J; Frei E
    Gen Physiol Biophys; 2006 Sep; 25(3):245-61. PubMed ID: 17197724
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Characterization of the metabolites of ellipticine in rat bile.
    Branfman AR; Bruni RJ; Reinhold VN; Silveira DM; Chadwick M; Yesair DW
    Drug Metab Dispos; 1978; 6(5):542-8. PubMed ID: 30603
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolism and disposition studies of 9-hydroxyellipticine and 2-methyl-9-hydroxyellipticinium acetate in animals.
    Van-Bac N; Moisand C; Gouyette A; Muzard G; Dat-Xuong N; Le Pecq JB; Paoletti C
    Cancer Treat Rep; 1980; 64(8-9):879-87. PubMed ID: 7448826
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Bioactivation of the antitumor drugs 9-hydroxyellipticine and derivatives by a peroxidase-hydrogen peroxide system.
    Auclair C; Paoletti C
    J Med Chem; 1981 Mar; 24(3):289-95. PubMed ID: 7265115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Metabolic transformation of 2-methylellipticinium.
    Malvy C; Paoletti C
    Biochem Biophys Res Commun; 1980 Sep; 96(1):363-9. PubMed ID: 7437041
    [No Abstract]   [Full Text] [Related]  

  • 11. Synthesis of deuterium-labelled elliptinium and its use in metabolic studies.
    Gouyette A
    Biomed Environ Mass Spectrom; 1988 Mar; 15(5):243-7. PubMed ID: 3365494
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for electrophilic properties of N2-methyl-9-hydroxy ellipticinium acetate (Celiptium) from human biliary metabolites.
    Bernadou J; Monsarrat B; Roche H; Armand JP; Paoletti C; Meunier B
    Cancer Chemother Pharmacol; 1985; 15(1):63-5. PubMed ID: 4006051
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Mutagenicity and cytotoxicity of five antitumor ellipticines in mammalian cells and their structure-activity relationships in Salmonella.
    DeMarini DM; Cros S; Paoletti C; Lecointe P; Hsie AW
    Cancer Res; 1983 Aug; 43(8):3544-52. PubMed ID: 6344986
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Demonstration of the O-demethylation reaction catalyzed by a peroxidase: application to 9-methoxyellipticine].
    Meunier G; Paoletti C; Meunier B
    C R Acad Sci III; 1984; 299(15):629-32. PubMed ID: 6440666
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of the 6-alkyl substitution of ellipticine on the uptake by NIH-3T3 cells and on the cytotoxicity.
    Deprés JP; Larue L; Paoletti J; Gouyette A
    Anticancer Res; 1988; 8(1):191-6. PubMed ID: 3358635
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The hydroxylation of the antitumor agent, ellipticine, by liver microsomes from differently pretreated rats.
    Lesca P; Lecointe P; Paoletti C
    Biochem Pharmacol; 1977 Nov; 26(22):2169-73. PubMed ID: 588300
    [No Abstract]   [Full Text] [Related]  

  • 17. The rat biliary and urinary metabolism of the N6-methylated derivative of elliptinium acetate, and antitumor agent.
    Braham Y; Meunier G; Meunier B
    Drug Metab Dispos; 1988; 16(2):316-21. PubMed ID: 2898353
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mammalian peroxidases activate anticancer drug ellipticine to intermediates forming deoxyguanosine adducts in DNA identical to those found in vivo and generated from 12-hydroxyellipticine and 13-hydroxyellipticine.
    Stiborová M; Poljaková J; Ryslavá H; Dracínský M; Eckschlager T; Frei E
    Int J Cancer; 2007 Jan; 120(2):243-51. PubMed ID: 17066455
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microbial transformations of natural antitumor agents. 9. O-Demethylation of 9-methoxyellipticine.
    Chien MM; Rosazza JP
    J Nat Prod; 1979; 42(6):643-7. PubMed ID: 575547
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Biotransformation of letrozole in rat liver microsomes: effects of gender and tamoxifen.
    Tao X; Piao H; Canney DJ; Borenstein MR; Nnane IP
    J Pharm Biomed Anal; 2007 Feb; 43(3):1078-85. PubMed ID: 17045772
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.